Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and evernimicin

vancomycin has been researched along with evernimicin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chahrour, T; Mariano, N; Mosinka-Snipas, K; Rahal, JJ; Urban, C; Wadee, C1
Beauchamp, D; Bergeron, MG; Bergeron, Y; Simard, M; Wang, E1
Eliopoulos, GM; Souli, M; Thauvin-Eliopoulos, C1
Iba, Y; Kamei, C; Sugimoto, Y; Utsugi, K1
Boucher, HW; Eliopoulos, GM; Loebenberg, D; Thauvin-Eliopoulos, C1
Saxén, H; Vaara, M1

Reviews

1 review(s) available for vancomycin and evernimicin

ArticleYear
[New antibacterial agents].
    Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:20

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin

1999

Other Studies

5 other study(ies) available for vancomycin and evernimicin

ArticleYear
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin

1996
In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Female; Leukopenia; Lung; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Serum Bactericidal Test; Streptococcus pneumoniae; Survival Analysis; Vancomycin

2000
In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Enterococcus faecium; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Vancomycin; Vancomycin Resistance

2000
Influences of everninomicin, vancomycin and teicoplanin on chemical mediator release from rat peritoneal mast cells.
    Japanese journal of pharmacology, 2000, Volume: 83, Issue:4

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Concanavalin A; Histamine Release; Male; Mast Cells; Prostaglandin D2; Rats; Rats, Wistar; Teicoplanin; Vancomycin

2000
In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Endocarditis, Bacterial; Male; Methicillin Resistance; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2001